MedTrace Logo

Tamsulosin as Adjunctive Therapy After Extracorporeal Shock Wave Lithotripsy for Renal Stones

NCT04819828 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-04-01

No results posted yet for this study

Summary

Urolithiasis is a common health problem worldwide affecting approximately 10% of the population at some stage in their lives. The aim of this study is to evaluate the efficacy of adjuvant treatment with tamsulosin for improving the stone-free rate after a single session of extracorporeal shock wave lithotripsy (ESWL) in the treatment of radiopaque kidney stones.

Conditions

  • Renal Stone

Interventions

PROCEDURE

Extracorporeal shock wave lithotripsy

A single session of extracorporeal shock wave lithotripsy: the session will be finished upon reaching a maximum of 4,000 shocks or if a complete fragmentation of the kidney stone is observed.

DRUG

Diclofenac

Standard treatment for analgesia: oral diclofenac (75 mg/12 h) as needed.

DRUG

Tamsulosin

Oral tamsulosin (0.4 mg/day) for eight weeks.

Sponsors & Collaborators

  • Hospital Regional de Alta Especialidad del Bajio

    lead OTHER

Principal Investigators

  • Rafael E Maldonado-Valadez, MD, MSc · Hospital Regional de Alta Especialidad del Bajio

  • Edel R Rodea-Montero, MPH · Hospital Regional de Alta Especialidad del Bajio

  • Jose A Alvarez-Canales, MD, Phd · Hospital Regional de Alta Especialidad del Bajio

  • Angel D Valdez-Vargas, MD · Hospital Regional de Alta Especialidad del Bajio

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-01
Primary Completion
2016-08-31
Completion
2016-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04819828 on ClinicalTrials.gov